Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Roche Seeks Diagnostics To Pair With Cancer Drugs In $3 Billion Ventana Bid

Executive Summary

Roche's $3 billion hostile takeover bid for Ventana Medical Systems is aimed at providing the drug and diagnostics giant with platform technology for tissue-based diagnostic tests to pair with targeted cancer drugs, the company says

You may also be interested in...



Pharmacogenomics Draft Guidance Needs Clarification, Industry Tells FDA

Industry is pressing FDA to enhance the utility of its "companion guidance" on pharmacogenomic data submissions as the agency refines the draft document

Pharmacogenomics Draft Guidance Needs Clarification, Industry Tells FDA

Industry is pressing FDA to enhance the utility of its "companion guidance" on pharmacogenomic data submissions as the agency refines the draft document

Roche Diagnostics CEO Is No Ugly Duckling: Schwan Picked To Head Parent Corp.

Roche Diagnostics CEO Severin Schwan will succeed Franz Humer as CEO of Roche, reflecting a two-fold strategy to separate the chairman and CEO roles and to effect a generational management transition, the drug and diagnostics giant announced July 19

Related Content

UsernamePublicRestriction

Register

ID1132956

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel